vimarsana.com

Latest Breaking News On - Adjuvant nivolumab - Page 1 : vimarsana.com

Regulatory Filings Accepted for Perioperative Nivolumab Plus Chemotherapy in NSCLC

The FDA and EMA have accepted applications seeking the approval of neoadjuvant nivolumab/chemotherapy followed by surgery and adjuvant nivolumab in NSCLC.

Dr Galsky on the Efficacy of Adjuvant Nivolumab in the CheckMate 274 Trial in mUC

Matthew Galsky, MD, discusses how updated findings from the phase 3 CheckMate 274 study confirm the efficacy of adjuvant systemic immunotherapy in metastatic urothelial carcinoma.

Adjuvant Treatment Approaches in Muscle-Invasive Bladder Cancer

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.